{"count": 6, "results": [{"_id": "2975684", "pmid": 2975684, "title": "Atenolol treatment of late luteal phase dysphoric disorder.", "journal": "J Affect Disord", "authors": ["Rausch JL", "Janowsky DS", "Golshan S", "Kuhn K", "Risch SC"], "date": "1988-09-01T00:00:00Z", "doi": "10.1016/0165-0327(88)90082-1", "meta_date_publication": "1988 Sep-Oct", "meta_volume": "15", "meta_issue": "2", "meta_pages": "141-7", "score": 50066.105, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ treatment of late luteal phase @DISEASE_Premenstrual_Dysphoric_Disorder @DISEASE_MESH:D065446 @@@dysphoric disorder@@@.", "citations": {"NLM": "Rausch JL, Janowsky DS, Golshan S, Kuhn K, Risch SC. Atenolol treatment of late luteal phase dysphoric disorder. J Affect Disord. 1988 Sep-Oct;15(2):141-7. PMID: 2975684", "BibTeX": "@article{2975684, title={Atenolol treatment of late luteal phase dysphoric disorder.}, author={Rausch JL and Janowsky DS and Golshan S and Kuhn K and Risch SC}, journal={J Affect Disord}, volume={15}, number={2}, pages={141-7}}"}}, {"_id": "10425617", "pmid": 10425617, "title": "[Relationship between sympathetic activity and response to treatment with atenolol in hypertensive patients. Investigation group of the study of efficiency and tolerance of atenolol in hypertensive patients with increase in the sympathetic activity].", "journal": "Med Clin (Barc)", "authors": ["de la Sierra A"], "date": "1999-06-19T00:00:00Z", "meta_date_publication": "1999 Jun 19", "meta_volume": "113", "meta_issue": "2", "meta_pages": "41-5", "score": 50061.8, "text_hl": "CONCLUSION: Baseline @DISEASE_Tachycardia @DISEASE_MESH:D013610 @@@tachycardia@@@ or symptoms suggesting @DISEASE_Anxiety @DISEASE_MESH:D001007 @@@anxiety@@@, @<m>DISEASE_Tension_Type_Headache</m> @DISEASE_MESH:D018781 @@@emotional tension@@@ or @DISEASE_Urinary_Bladder_Overactive @DISEASE_MESH:D053201 @@@sympathetic overactivity@@@ are associated with a more pronounced blood @DISEASE_Pressure_Ulcer @DISEASE_MESH:D003668 @@@pressure@@@ fall to antihypertensive treatment with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@. ", "citations": {"NLM": "de la Sierra A. [Relationship between sympathetic activity and response to treatment with atenolol in hypertensive patients. Investigation group of the study of efficiency and tolerance of atenolol in hypertensive patients with increase in the sympathetic activity]. Med Clin (Barc). 1999 Jun 19;113(2):41-5. PMID: 10425617", "BibTeX": "@article{10425617, title={[Relationship between sympathetic activity and response to treatment with atenolol in hypertensive patients. Investigation group of the study of efficiency and tolerance of atenolol in hypertensive patients with increase in the sympathetic activity].}, author={de la Sierra A}, journal={Med Clin (Barc)}, volume={113}, number={2}, pages={41-5}}"}}, {"_id": "6848299", "pmid": 6848299, "title": "Central effects of beta-adrenoceptor antagonists.", "journal": "Clin Pharmacol Ther", "authors": ["Salem SA", "McDevitt DG"], "date": "1983-01-01T00:00:00Z", "doi": "10.1038/clpt.1983.7", "meta_date_publication": "1983 Jan", "meta_volume": "33", "meta_issue": "1", "meta_pages": "52-7", "score": 50060.355, "text_hl": "The results show that @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ exerts central effects in man.", "citations": {"NLM": "Salem SA, McDevitt DG. Central effects of beta-adrenoceptor antagonists. Clin Pharmacol Ther. 1983 Jan;33(1):52-7. PMID: 6848299", "BibTeX": "@article{6848299, title={Central effects of beta-adrenoceptor antagonists.}, author={Salem SA and McDevitt DG}, journal={Clin Pharmacol Ther}, volume={33}, number={1}, pages={52-7}}"}}, {"_id": "3356086", "pmid": 3356086, "title": "Short-term behavioral effects of beta-adrenergic medications in men with mild hypertension.", "journal": "Clin Pharmacol Ther", "authors": ["Blumenthal JA", "Madden DJ", "Krantz DS", "Light KC", "McKee DC", "Ekelund LG", "Simon J"], "date": "1988-04-01T00:00:00Z", "doi": "10.1038/clpt.1988.54", "meta_date_publication": "1988 Apr", "meta_volume": "43", "meta_issue": "4", "meta_pages": "429-35", "score": 50048.4, "text_hl": "Reductions in negative emotional states (@<m>DISEASE_Tension_Type_Headache</m> @DISEASE_MESH:D018781 @@@tension@@@ and anger) were observed for subjects receiving @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@, and the largest improvements in memory performance were observed for subjects receiving @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@. ", "citations": {"NLM": "Blumenthal JA, Madden DJ, Krantz DS, Light KC, McKee DC, Ekelund LG, Simon J. Short-term behavioral effects of beta-adrenergic medications in men with mild hypertension. Clin Pharmacol Ther. 1988 Apr;43(4):429-35. PMID: 3356086", "BibTeX": "@article{3356086, title={Short-term behavioral effects of beta-adrenergic medications in men with mild hypertension.}, author={Blumenthal JA and Madden DJ and Krantz DS and Light KC and McKee DC and Ekelund LG and Simon J}, journal={Clin Pharmacol Ther}, volume={43}, number={4}, pages={429-35}}"}}, {"_id": "16362700", "pmid": 16362700, "pmcid": "PMC3452015", "title": "Weight variations in the prophylactic therapy of primary headaches: 6-month follow-up", "journal": "J Headache Pain", "authors": ["Maggioni F", "Ruffatti S", "Dainese F", "Mainardi F", "Zanchin G"], "date": "2005-09-01T00:00:00Z", "doi": "10.1007/s10194-005-0221-y", "meta_date_publication": "2005 Sep", "meta_volume": "6", "meta_issue": "4", "meta_pages": "322-4", "score": 50044.81, "text_hl": "We conclude that @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@, @CHEMICAL_Gabapentin @CHEMICAL_MESH:D000077206 @@@gabapentin@@@, @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@, @CHEMICAL_Verapamil @CHEMICAL_MESH:D014700 @@@verapamil@@@ and @CHEMICAL_Valproic_Acid @CHEMICAL_MESH:D014635 @@@valproate@@@ affect body weight in a modest percentage of @SPECIES_9606 @@@patients@@@ at 6 months. ", "citations": {"NLM": "Maggioni F, Ruffatti S, Dainese F, Mainardi F, Zanchin G. Weight variations in the prophylactic therapy of primary headaches: 6-month follow-up J Headache Pain. 2005 Sep;6(4):322-4. PMID: 16362700", "BibTeX": "@article{16362700, title={Weight variations in the prophylactic therapy of primary headaches: 6-month follow-up}, author={Maggioni F and Ruffatti S and Dainese F and Mainardi F and Zanchin G}, journal={J Headache Pain}, volume={6}, number={4}, pages={322-4}}"}}, {"_id": "16342054", "pmid": 16342054, "title": "[Refractory hypertention in a female patient with renal failure].", "journal": "G Ital Nefrol", "authors": ["Zuccalà A", "Losinno F", "Fiorenza S", "Lifrieri F", "Rapanà R"], "date": "2005-11-01T00:00:00Z", "meta_date_publication": "2005 Nov-Dec", "meta_volume": "22", "meta_issue": "6", "meta_pages": "617-20", "score": 50040.863, "text_hl": "Three months after the manoeuvre the @SPECIES_9606 @@@patient@@@ was again referred to our unit with @DISEASE_Headache @DISEASE_MESH:D006261 @@@headache@@@, @DISEASE_Postoperative_Nausea_and_Vomiting @DISEASE_MESH:D020250 @@@nausea vomiting@@@ and @<m>DISEASE_Tension_Type_Headache</m> @DISEASE_MESH:D018781 @@@hyper-tension@@@ refractory to @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@ 10 mg/day, @CHEMICAL_Doxazosin @CHEMICAL_MESH:D017292 @@@doxazosine@@@ 4 mg twice a a day, @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ 50 mg/day, @CHEMICAL_Furosemide @CHEMICAL_MESH:D005665 @@@furosemide@@@ 50 mg/day. ", "citations": {"NLM": "Zuccalà A, Losinno F, Fiorenza S, Lifrieri F, Rapanà R. [Refractory hypertention in a female patient with renal failure]. G Ital Nefrol. 2005 Nov-Dec;22(6):617-20. PMID: 16342054", "BibTeX": "@article{16342054, title={[Refractory hypertention in a female patient with renal failure].}, author={Zuccalà A and Losinno F and Fiorenza S and Lifrieri F and Rapanà R}, journal={G Ital Nefrol}, volume={22}, number={6}, pages={617-20}}"}}]}